This fatal occurrence was reported in a patient with metastatic colorectal cancer following the administration of ERBB2 CAR-Ts where low expression of ERBB2 on respiratory normal epithelial cells led to acute pulmonary manifestation and the patient’s death 5 days after the injection of CAR-Ts [72]. Here, ERBB2 is linked to metastatic colorectal cancer.